drugset / Trial / NCT05837104
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to assess the efficacy and safety of Magnesium-vitamin B6in combination with treatment as usual for treating symptoms of depression, stress, and anxiety in patients with first episode bipolar I disorder.
Timeline
- Start
- 2023-12-13
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 100 mg | Oral |
| Subject | Pyridoxine | Unknown | 10 mg | Oral |